Bioactive peptides: Applications and relevance for cosmeceuticals

Cosmetics

Volumn 5, Issue 1, 2018, Pages

  Lima, Tamyres Nassa ^a   Moraes, Carla Aparecida Pedriali ^a  

^a FATEC Diadema Luigi Papaiz   (Brazil)

Author keywords

Bioactive peptides; Growth factor; Neuropeptides

Indexed keywords

EID: 85051588647     PISSN: None     EISSN: 20799284     Source Type: Journal    
DOI: 10.3390/cosmetics5010021     Document Type: Review

References (41)

1. Machado, A.; Liria, C.W.; Proti, P.B.; Remuzgo, C.; Miranda, M.T.M. Síntese química e enzimática de peptídeos: Princípios e aplicações. Quim. Nova 2004, 5, 781-789
2. Peptide Therapeutics Market (by Applications, by Route of Administration, and by Marketing Status)-Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014-2020. April 2017. Available online: http://www.transparencymarketresearch.com/pressrelease/peptide-therapeutics-market.htmd (accessed on 1 October 2017)
3. Global Cosmeceuticals Market Outlook 2020. RNCOS E-Services Pvt. Ltd., July 2017. Available online: http://www.giiresearch.com/report/rnc263147-global-cosmeceutical-market-outlook.html (accessed on 1 October 2017)
4. Linder, J. The science behind peptides. Plast. Surg. Nurs. 2012, 32, 71-72
5. Zhang, L.; Falla, T.J. Cosmeceuticals and peptides. Clin. Dermatol. 2009, 27, 485-494
6. Gaspar, P.K. Neuropeptides in the skin. An. Bras. Dermatol. 2003, 78, 483-498
7. Scholzen, T.; Armstrong, C.; Burnett, N.; Luger, T.; Olerud, J.; Ansel, J. Neuropeptides in the skin: Interactions between the neuroendocrine and the skin immune systems. Exp. Dermatol. 1998, 7, 81-96
8. Guimaraes, D.E.D.; Sardinha, F.L.C.; Mizurini, D.M.; Carmo, M.G.T. Adipocinas: Uma nova visão do tecido adipose. Rev. Nutr. 2007, 20, 549-559
9. Claeys, I.; Simonet, G.; Poels, J.; Loy, T.V.; Vercamme, L.; Loof, A.; Broeck, J.V. Insulin-related peptides and their conserved signal transduction pathway. Peptides 2002, 23, 807-816
10. Gazitaeva, Z.I.; Drobintseva, A.O.; Chung, Y.; Polyakova, V.O.; Kvetnoy, I.M. Cosmeceutical product consisting of biomimetic peptides: Antiaging effects in vivo and in vitro. Clin. Cosmet. Investig. Dermatol. 2017, 10, 11-16
11. Pai, V.V.; Bhandari, P.; Shukla, P. Topical peptides as cosmeceuticals. Indian J. Dermatol. Venereol. Leprol. 2017, 83, 9-18
12. Fields, K.; Falla, T.J.; Rodan, K.; Bush, L. Bioactive peptides: Signaling the future. J. Cosmet. Dermatol. 2009, 8, 8-13
13. Lintner, K.; Mas-Chamberlin, C.; Mondon, P.; Peschard, O.; Lamy, L. Cosmeceuticals and active ingredients. Clin. Dermatol. 2009, 27, 461-468
14. Gorouhi, F.; Maibach, H. Role of topical peptides in preventing or treating aged skin. Int. J. Cosmet. Sci. 2009, 31, 327-345
15. Siméon, A.; Monier, F.; Emonard, H.; Gillery, P.; Birembaut, P.; Hornebeck, W.; Maquart, F.X. Expression and activation of matrix metalloproteinases in wounds: Modulation by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. J. Investig. Dermatol. 1999, 112, 957-964
16. Netto, J.C.; Mendonça, R.J. Aspectos celulares da cicatrização. An. Bras. Dermatol. 2009, 84, 257-262
17. Carpenter, G.; Cohen, S. Epidermal growth factor. J. Biol. Chem. 1990, 265, 7709-7712
18. Suter, F.; Schmid, D.; Wandrey, F.; Zulli, F. Heptapeptide-loaded solid lipid nanoparticles for cosmetic anti-aging applications. Eur. J. Pharm. Biopharm. 2016, 108, 304-309
19. MIBELLE GROUP BIOCHEMISTRY. Paris: PERFECTION PEPTIDE-P7®. Available online: https:// mibellebiochemistry.com/products/perfectionpeptide-p7/ (accessed on 28 October 2017)
20. Pratchyapurit, W.O. Combined use of two formulations containing diacetyl boldine, TGF-β1 biomimetic oligopeptide-68 with other hypopigmenting/exfoliating agents and sunscreen provides effective and convenient treatment for facial melasma. Either is equal to or is better than 4% hydroquinone on normal skin. J. Cosmet. Dermatol. 2016, 15, 95-101
21. BIOTEC. São Paulo: β. WHITE™. Available online: http://www.biotecdermo.com.br/b-white/ (accessed on 31 August 2017)
22. Halbe, H.W.; Cunha, D.C. O Excesso do órgão adiposo. Diagn. Tratamento 2008, 13, 153-160
23. PHARMASPECIAL. São Paulo: LIPOXYN®. Available online: http://www.pharmaspecial.com.br/media/ produtos/_lit_lipoxyn.pdf (accessed on 30 June 2017)
24. 2+ stimulates matrix metalloproteinase-2 expression by fibroblast cultures. Life Sci. 2000, 67, 2257-2265
25. Finkley, M.; Appa, Y.; Bhandarkar, S. Copper peptide and skin. In Cosmeceuticals and Active Cosmetics: Drugs vs. Cosmetics; Elsner, P., Maibach, H., Eds.; Marcel Dekker Press: New York, NY, USA, 2005; pp. 549-563
26. Blanes-Mira, C.; Clemente, J.; Jodas, G.; Gil, A.; Fernández-Ballester, G.; Ponsati, B.; Gutierrez, L.; Pérez-Payá, E.; Ferre-Montiel, A. A synthetic hexapeptide (Argireline) with antiwrinkle activity. Int. J. Cosmet. Sci. 2002, 24, 303-310
27. Wang, Y.; Wang, M.; Xiao, S.; Pan, P.; Li, P.; Huo, J. The anti-wrinkle efficacy of argireline, a synthetic hexapeptide, in Chinese subjects: A randomized, placebo-controlled study. Am. J. Clin. Dermatol. 2013, 14, 147-153
28. Kang, A.; Shults, A.; Zhao, Y. Argireline decreases EPSP amplitude over time, and increases paired-pulse facilitation in a dose-dependent manner. Eur. J. Neurosci. 2015, 15, 17-23
29. Ruiz, M.A.; Clares, B.; Morales, M.E.; Gallardo, V. Evaluation of the anti-wrinkle efficacy of cosmetic formulations with an anti-aging peptide (Argireline®). ARS Pharm. 2010, 50, 168-176
30. GALENA. São Paulo: ARGIRELINE®. Available online: http://www.pharmakondf.com.br/Pharmakon/ arquivos/INSUMOS_FARMACEUTICOS/A/6213_-_IC_-_ARGIRELINE.pdf (accessed on 25 June 2017)
31. Petit, J.L.V.; Gonzalez, R.D.; Botello, A.F. Nanocapsules Containing Microemulsions. U.S. Patent 20, 130, 216, 596, 22 August 2013
32. GALENA. São Paulo: VANISTRYL®. Available online: http://www.farmacianaturalfarma.com.br/noticias/ 7ae84ef6051d941223a415ddf24b38d3.pdf (accessed on 25 April 2017)
33. Slominski, A.; Wortsman, J. Neuroendocrinology of the skin. Endocr. Rev. 2000, 21, 457-487
34. Fuller, R.W.; Conradson, T.B.; Dixon, C.M.; Crossman, D.C.; Barnes, P.J. Sensory neuropeptide effects in human skin. Br. J. Pharmacol. 1987, 92, 781-788
35. Millington, G.W. Proopiomelanocortin (POMC): The cutaneous roles of its melanocortin products and receptors. Clin. Exp. Dermatol. 2006, 31, 407-412
36. Fatemi, S.A.; Dehkordi, A.J.; Haijhashemi, V.; Mahabadi, A.A. Biomimetic proopiomlanocortin suppress capsaicin-induced sensory irritation in humans. Res. Pharm. Sci. 2016, 11, 484-490
37. MIBELLE GROUP BIOCHEMISTRY. Paris: HAPPYBELLE-PE®. Available online: https://mibellebiochemistry. com/products/happybelle-pe/ (accessed on 26 December 2017)
38. Safety Assessment of Palmitoyl Oligopeptides as Used in Cosmetics. Available online: http://www.cirsafety. org/sites/default/files/palmit072012slr.pdf (accessed on 22 April 2017)
39. Maia Campos, P.M.G.; Mercúrio, D.G.; Tadini, K.A. Acetyl hexapeptide-3 in a cosmetic formulation acts on skin mechanical properties-Clinical study. Braz. J. Pharm. Sci. 2015, 51, 901-909
40. Safety Assessment of Tripeptide-1, Hexapeptide-12, Their Metal Salts and Fatty Acyl Derivatives, and Palmitoyl Tetrapeptide-7 as Used in Cosmetics. Available online: https://www.cir-safety.org/sites/default/ files/tripep062014final.pdf (accessed on 22 April 2017)
41. Pickart, L.; Lovejoy, S. Biological activity of human plasma copper-binding growth factor glycyl-L-histidyl-Llysine. Methods Enzymol. 1987, 147, 314-328